ARWR – Arrowhead Pharmaceuticals, Inc.

Arrowhead Pharmaceuticals, Inc.

ARWR

$73.33

Name : Arrowhead Pharmaceuticals, Inc.

Sector : Healthcare

Industry: Biotechnology

Mark. Cap: $10,329,046,016.00

EPSttm : -2.27

Arrowhead Pharmaceuticals, Inc.

$73.33

0.72%

$0.53

ARWR — Price & Float Short

—— Fair value ★ EPS beat ★ EPS miss —— Target Price

Float Short %

9.77

Margin Of Safety %

Put/Call OI Ratio

0.57

EPS Next Q Diff

-0.2

EPS Last/This Y

-2.99

EPS This/Next Y

-1.34

Price

73.33

Target Price

88.45

Analyst Recom

1.46

Performance Q

23.87

Upside

-138.1%

Beta

1.28

Ticker: ARWR

20 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-05-11	ARWR	77.76	0.46	0.45	37607
2026-05-12	ARWR	79.06	0.47	0.38	37825
2026-05-13	ARWR	77.91	0.47	0.55	38353
2026-05-14	ARWR	79.66	0.47	0.98	37792
2026-05-15	ARWR	76.69	0.48	0.50	37892
2026-05-18	ARWR	73.94	0.46	3.31	33080
2026-05-19	ARWR	73.16	0.50	0.45	34255
2026-05-20	ARWR	77.12	0.51	4.31	34411
2026-05-21	ARWR	75.53	0.55	3.01	35690
2026-05-22	ARWR	74.91	0.57	1.85	36214
2026-05-26	ARWR	78.68	0.57	0.03	36371
2026-05-27	ARWR	78.96	0.56	0.42	36729
2026-05-28	ARWR	79.02	0.56	0.29	37049
2026-05-29	ARWR	77.92	0.56	0.17	37154
2026-06-02	ARWR	70.82	0.56	0.51	37334
2026-06-03	ARWR	72.53	0.57	0.21	37831
2026-06-04	ARWR	75.12	0.57	0.17	38243
2026-06-05	ARWR	73.11	0.56	0.27	38452
2026-06-08	ARWR	73.88	0.57	0.24	38571
2026-06-09	ARWR	73.33	0.57	0.20	38590
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

20 items 1 of 1

21 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-05-11	ARWR	77.75	-139.0	-	-3.22
2026-05-12	ARWR	79.04	-3.7	-	-3.22
2026-05-13	ARWR	77.90	-3.7	-	-3.22
2026-05-14	ARWR	79.66	-3.7	-	-3.22
2026-05-15	ARWR	76.67	-3.7	-	-3.22
2026-05-18	ARWR	73.95	4.2	-	-2.97
2026-05-19	ARWR	73.17	4.2	-	-2.97
2026-05-20	ARWR	77.14	4.6	-	-3.00
2026-05-21	ARWR	75.53	4.6	-	-3.00
2026-05-22	ARWR	74.91	4.6	-	-3.00
2026-05-26	ARWR	78.67	4.6	-	-3.00
2026-05-27	ARWR	78.89	4.6	-	-3.00
2026-05-28	ARWR	78.98	4.6	-	-3.00
2026-05-29	ARWR	77.96	4.6	-	-3.00
2026-06-01	ARWR	75.18	4.6	-	-3.00
2026-06-02	ARWR	70.82	4.6	-	-3.00
2026-06-03	ARWR	72.56	4.6	-	-3.00
2026-06-04	ARWR	75.17	4.6	-	-3.00
2026-06-05	ARWR	73.09	4.6	-	-3.00
2026-06-08	ARWR	73.86	4.6	-	-3.00
2026-06-09	ARWR	73.33	4.6	-	-3.00
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

21 items 1 of 1

20 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-05-11	ARWR	-5.72	-2.44	9.11
2026-05-12	ARWR	-5.72	-2.44	9.81
2026-05-13	ARWR	-5.72	-2.44	9.81
2026-05-14	ARWR	-5.72	-2.44	9.81
2026-05-15	ARWR	-5.75	-2.44	9.81
2026-05-18	ARWR	-5.75	-2.55	9.81
2026-05-19	ARWR	-5.75	-2.55	9.82
2026-05-20	ARWR	-5.69	-2.55	9.82
2026-05-21	ARWR	-5.69	-2.55	9.78
2026-05-22	ARWR	-6.01	-2.55	9.78
2026-05-26	ARWR	-6.01	4.64	9.78
2026-05-27	ARWR	-6.01	4.64	9.78
2026-05-28	ARWR	-6.01	4.64	9.77
2026-05-29	ARWR	-6.01	4.64	9.77
2026-06-02	ARWR	-5.92	4.31	9.77
2026-06-03	ARWR	-5.92	4.31	9.77
2026-06-04	ARWR	-5.92	4.31	9.77
2026-06-05	ARWR	-5.92	4.31	9.77
2026-06-08	ARWR	-5.92	4.38	9.77
2026-06-09	ARWR	-5.92	4.38	9.77
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

20 items 1 of 1

Last Quarter Act. EPS

-0.93

Avg. EPS Est. Current Quarter

-1.2

Avg. EPS Est. Next Quarter

-1.13

Insider Transactions

-5.92

Institutional Transactions

4.38

Beta

1.28

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

21.7

Max Drawdown 5-Year %

-88.9

Target Price

88.45

P/E

Forward P/E

PEG

P/S

16.61

P/B

16.79

P/Free Cash Flow

EPS

-2.15

Average EPS Est. Cur. Y

-3

EPS Next Y. (Est.)

-4.34

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-48.38

Relative Volume

0.72

Return on Equity vs Sector %

-76.5

Return on Equity vs Industry %

-60.3

EPS 1 7Days Diff

EPS 1 30Days Diff

0.24

EBIT Estimation

◆ ARWR Healthcare

$73.33

📉

Swing / Pullback

Buy the dip on strong trends

N/A

WEAK

Trend

2/20

Pullback

21/25

Volume

9/15

Valuation

8/20

TP/AR

4/10

Options

6/10

RSI

Range 1M

29.3%

Sup Dist

0.9%

🚀

Momentum Growth

Ride accelerating trends

N/A

WEAK

Momentum

5/25

Growth

6/30

Estimates

2/20

Inst/Vol

8/15

Options

9/10

EPS Yr

-31101.5%

EPS NY

-24.8%

52W%

86.5%

💎

Long-Term Value

Quality companies, undervalued

N/A

WEAK

🟡 HOLD +20.6% upside

Quality

6/30

Valuation

7/30

Growth

4/25

Stability

6/10

LT Trend

0/5

Upside

+20.6%

Quality

Arrowhead Pharmaceuticals, Inc.

Sector: Healthcare

Industry: Biotechnology

Employees: 711

Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. Its pipeline includes Plozasiran to reduce production of apolipoprotein C-III in Phase 3 studies; Zodasiran to reduce production of angiopoietin-like protein 3 in Phase 3 clinical trials; ARO-DIMER-PA, a dual functional RNAi molecule in a Phase 1/2a clinical trials; and ARO-PNPLA3, an investigational RNAi therapeutic in Phase 1 clinical trials. The company also develops ARO-INHBE, to reduce the hepatic expression of the INHBE gene and its secreted gene product, Activin E in Phase 1/2a clinical trials; ARO-ALK7 to silence adipocyte expression of the ACVR1C gene in Phase 1/2a clinical trials; ARO-RAGE to reduce production of the receptor for advanced glycation end products in Phase 1/2a clinical trials; and ARO-MAPT, an investigational RNAi-based therapy. In addition, it is developing ARO-C3 to reduce production of C3 in Phase 1/2a clinical trials; and ARO-CFB to reduce hepatic expression of CFB in a Phase 1/2a clinical trials. The company has collaboration and license Agreements with Glaxosmithkline Intellectual Property (No. 3) Limited; Takeda Pharmaceutical Company Limited; Amgen Inc.; and Sarepta Therapeutics, Inc. Arrowhead Pharmaceuticals, Inc. was founded in 2003 and is headquartered in Pasadena, California.

ARWR

Latest News

—

Caricamento notizie per ARWR…

stock quote shares ARWR – Arrowhead Pharmaceuticals, Inc. Stock Price stock today

news today ARWR – Arrowhead Pharmaceuticals, Inc. stock forecast ,stock prediction 2023 2024 2025

marketwatch ARWR – Arrowhead Pharmaceuticals, Inc. yahoo finance google finance

stock history ARWR – Arrowhead Pharmaceuticals, Inc. invest stock market

stock prices ARWR premarket after hours

ticker ARWR fair value insiders trading

ARWR – Arrowhead Pharmaceuticals, Inc.

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Upside

Beta

Ticker: ARWR

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Latest News

Last Quarter Act. EPS

Average EPS Est. Cur. Y